Search results for "Prostate Cancer"
MKSAP Quiz: Exacerbations of heart failure
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018
Patients and priorities in prostate cancer care
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
https://immattersacp.org/archives/2017/11/patients-and-priorities-in-prostate-cancer-care.htm
1 Nov 2017
‘Smart’ drugs could be bad idea
This issue covers performance-enhancing drugs, prostate cancer options, and transgender health.
https://immattersacp.org/archives/2017/11/smart-drugs-could-be-bad-idea.htm
1 Nov 2017
Prescribing for opioid addiction meds, CNS suppressants
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/11/prescribing-for-opioid-addiction-meds-cns-suppressants.htm
1 Nov 2017
High-value management of patients with GI symptoms
Gastroesophageal reflux disease, rectal bleeding, and chronic diarrhea can be controlled better by applying high-value care.
https://immattersacp.org/archives/2017/06/gastro.htm
1 Jun 2017
MKSAP Quiz: 2-year history of low libido
A 37-year-old man is evaluated for a 2-year history of low libido, loss of morning erections, fatigue, and decreasing muscle mass. His medical history is otherwise unremarkable. He takes no medications. A physical exam, lab studies, and pituitary MRI are done. Before starting therapy for this patient, what else should be determined?
https://immattersacp.org/weekly/archives/2017/05/09/3.htm
9 May 2017
Task Force draft recommendation leaves PSA screening choice up to patients
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017
Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes
More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Studies find rates of PSA screening, incidence of early-stage prostate cancer declining
An editorial called for personalized screening strategies that are tailored to a man's individual risk and preferences.
https://immattersacp.org/weekly/archives/2015/11/24/1.htm
24 Nov 2015